{
  "docId": "019de077-2c47-761e-b626-85ba7f6301f4",
  "docSlug": "dee393bba0eab79d9a8834e1f112398e",
  "documentTitle": "Kenvue | Results Presentation Deck | 37 slides",
  "authorId": "kenvue",
  "authorName": "Kenvue",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 12,
  "pageCount": 37,
  "prevPage": 11,
  "nextPage": 13,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 6,
  "notes": "Includes brand logos at the bottom.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de077-2c47-761e-b626-85ba7f6301f4/12",
  "deckHref": "/decks/019de077-2c47-761e-b626-85ba7f6301f4",
  "deckJsonHref": "/decks/019de077-2c47-761e-b626-85ba7f6301f4.json",
  "deckAnchorHref": "/decks/019de077-2c47-761e-b626-85ba7f6301f4#slide-12",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.92,
        "x": 0.04,
        "y": 0.78
      },
      "kind": "image",
      "text": "Brand logos: Tylenol, Zyrtec, Motrin, Zarbee's, Benadryl, Orsl, Nicorette, Rhinocort",
      "attrs": null,
      "subkind": "logo-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6f4b6ed6-d080-4ce6-9879-8146d4734b41",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.28,
        "x": 0.67,
        "y": 0.3
      },
      "kind": "list",
      "text": "Key Highlights: Continued share gains, Allergy performance, Nicorette performance",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7e0fac2b-d665-492f-971d-65332034efdc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.78,
        "x": 0.16,
        "y": 0.915
      },
      "kind": "source-note",
      "text": "1 Non-GAAP financial measure... 2 Value Realization reflects Price/Mix",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "055ee624-4a1a-429d-bcf6-7061359d9aa4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.944,
        "x": 0.028,
        "y": 0.168
      },
      "kind": "table",
      "text": "Net Sales and Organic Drivers table",
      "attrs": null,
      "subkind": "kpi",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "eff97e49-5350-40e0-a86f-acf08165340b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.41,
        "x": 0.028,
        "y": 0.045
      },
      "kind": "title",
      "text": "Self Care: Continued Share Gains",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4e8087a3-922b-42ac-8d70-f5c6821ce4ca",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 16,
      "from": 11,
      "beatId": "f1aa2bb7-d1f0-4a6c-82d9-9dae61af85b9",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "Financial performance and results provide satisfaction",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 16,
      "from": 5,
      "name": "Logic Chain",
      "slug": "01-logic-chain",
      "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
      "matchId": "37606457-501d-4e08-9aa6-c788736907bf",
      "evidence": "Logical sequence of financial results",
      "position": 0,
      "objective": "Understand Q2 2024 performance",
      "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
      "confidence": 0.7,
      "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
    },
    {
      "to": 13,
      "from": 8,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "3c3a904b-0825-4f95-990f-0e6151ff50af",
      "evidence": "Actions to stabilize U.S. Skin Health & Beauty",
      "position": 1,
      "objective": "Highlight stabilization plan",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}